Premalignant alterations in the glycosphingolipids of small intestinal mucosa of rats treated with 1,2-dimethylhydrazine.
1,2-Dimethylhydrazine is a procarcinogen with selectivity for the colon and proximal small intestine. In weekly subcutaneous (s.c.) doses of 20 mg/kg body weight, this agent produces colonic and proximal small intestinal tumors in a high percentage of rodents with a latency period of approximately six months. To determine whether alterations in the glycosphingolipid content of rat proximal and/or distal small intestinal mucosa existed before the development of dimethylhydrazine-induced cancer, rat were given s.c. injections of this agent (20 mg/kg body weight per wk) or diluent for five wk. Animals were killed at this time, and mucosa was isolated from each small intestinal segment of both groups. Glycosphingolipids then were extracted from these tissues and analyzed by high performance thin layer chromatography and gas liquid chromatography. The results of these studies demonstrated that (1) the content of neutral and acidic glycosphingolipids was significantly decreased (approximately 20%) in the proximal small intestine of treated rats compared with their control counterparts; (2) no significant difference in the glycosphingolipid content was seen, however, in the distal small intestinal mucosa of control and treated rats; and (3) while significant differences were noted in the majority of fatty acids of GM3, glucosyl- and globotriaosylceramide in the proximal small intestine of control and treated animals, differences in the fatty acids of these glycosphingolipids in the distal segment of these groups were confined to stearic (18:0) acid and/or arachidic (20:0) acid.
Dahiya
R
R
Department of Medicine, University of Chicago Hospitals and Clinics, IL 60637.
Dudeja
P K
PK
Brasitus
T A
TA
D019813:1,2-Dimethylhydrazine; D000818:Animals; D002241:Carbohydrates / Q000032:analysis; D002518:Ceramides / Q000302:isolation & purification; D002851:Chromatography, High Pressure Liquid; D004127:Dimethylhydrazines / Q000633:toxicity*; D005227:Fatty Acids / Q000032:analysis; D006028:Glycosphingolipids / Q000302:isolation & purification / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism; D007421:Intestine, Small / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008763:Methylhydrazines / Q000633:toxicity*; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D002241:Carbohydrates; D002518:Ceramides; D004127:Dimethylhydrazines; D005227:Fatty Acids; D006028:Glycosphingolipids; D008763:Methylhydrazines; D019813:1,2-Dimethylhydrazine